Sales Force effectiveness with Pharma CRM
Sales Vision Pharma CRM is a powerful strategic tool for sales/medical efficiency and helps to integrate marketing and sales in pharmaceutical companies. Sales Vision helps to manage medical representatives and KAM’s in pharmaceutical companies with more than 35 different pharmaceutical modules. Today we are one of the leading European Pharma CRM providers.
Progress means innovation. Innovation means thinking different. Our growth can be explained because our seek for innovate the pharmaceutical sales force effectiveness and marketing. As an example we have created the first native and offline iPhone Pharma CRM software. We also support and offer Sales Vision Pharma CRM as SAAS, cloud computing and on platforms such as web applications, PC offline versions, Windows pocket, mobile intelligence and iPhone version.
Our philosophy is to deliver a wide range of solutions with the Pharma CRM, like our e-testing solution ExpertVision, Sales Force effectiveness consulting, healthcare database, sales plans etc.
Our focus is to be a pharmaceutical partner in more than 30 countries and 26 different pharma companies. Sales Vision is a solution that was created to cover pharma needs, processes and trends. Pharmacentric since 1996.
HWA South Africa – new strategic partner for South Africa
London - Media-Soft Inc. partner family is expanding! We would like to introduce our new partner for South Africa, HWA Marketing and Sales Consulting, a consulting leader for the pharma business in South Africa. HWA has got the exclusive distribution right for Sales Vision Pharma CRM in around 10 different African countries. To enter in the [...]
L’Oreal implements Sales Vision Pharma CRM
Media-Soft would like to welcome the 28th pharma client worldwide, L’Oreal Adria who will implement Sales Vision Pharma CRM, the PC version called Sales Vision Pharma 9 in five countries.
We are very proud to have such a respectful new partner, who is a standard in the cosmetic industry but from our point of view also [...]
Nycomed’s first quarter 2010 results confirm the direction
Nycomed’s performance was driven by strong growth of Key Products and in most emerging markets. This overall positive performance could not fully offset the expected negative impact of pantoprazole’s patent expiry in Europe. Daxas® (roflumilast) is advancing well: Nycomed received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human [...]
Bayer Schering Pharma Enhances U.S. Research Strategy with New Innovation Center
Bayer Schering Pharma AG, Germany, will establish a U.S. Innovation Center in San Francisco, Calif. with the goal to expand its global research network and build its specialty pharmaceutical pipeline.
The model introduces a newly formed “Science Hub” for innovation sourcing in the U.S. creating collaborations with academic research scientists and small biotech firms to realize [...]
